益生菌
细菌
2019年冠状病毒病（COVID-19）
生物
微生物学
免疫
医学
免疫学
免疫系统
疾病
传染病（医学专业）
内科学
遗传学
作者
Indu Bhushan,Mahima Sharma,Malvika Mehta,Shivi Badyal,Varun Sharma,Indu Sharma,Hemender Singh,Srinivas Sistla
标识
DOI：10.1016/j.fshw.2021.02.001
摘要
The use of bioactive compounds and probiotic bacteria against the viral diseases in human is known for a long time. Anti-viral, anti-inflammatory and anti-allergic properties of bioactive compounds and bacteria with probiotic properties in respiratory viral diseases may have significance to enhance immunity. This review highlights some of the important bioactive compounds and probiotic bacteria, suggesting them as a ray of hope in the milieu of the COVID-19 management.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
Nole
yjh123
cdercder
东方元语
Kao
张欢馨
OK
v0id
dde
xing_xing
科研狗
aajhajkahna
行走的荷尔蒙
sagitar
天晴
啵啵
研友小福
Hayat
小小牛马
昏睡的蟠桃
皖公网安备34019202002308
